Haemonetics (HAE) News Today $65.76 -0.17 (-0.25%) Closing price 03/14/2025 03:59 PM EasternExtended Trading$65.26 -0.51 (-0.77%) As of 03/14/2025 04:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Charles Schwab Investment Management Inc. Grows Stock Holdings in Haemonetics Co. (NYSE:HAE)Charles Schwab Investment Management Inc. grew its holdings in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 1.6% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 551,193 shares of the medical instruments supplier's stock after purchasing an additionaMarch 15 at 3:25 AM | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Boosts Stock Position in Haemonetics Co. (NYSE:HAE)Connor Clark & Lunn Investment Management Ltd. boosted its holdings in Haemonetics Co. (NYSE:HAE - Free Report) by 14.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 252,142 shares of the medical instruments supplier's stock after acquiring anMarch 14 at 4:54 AM | marketbeat.com106,055 Shares in Haemonetics Co. (NYSE:HAE) Purchased by Wealthfront Advisers LLCWealthfront Advisers LLC bought a new stake in shares of Haemonetics Co. (NYSE:HAE - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 106,055 shares of the medical instruments supplier's stock, valued at approximately $7,849,0March 13 at 4:34 AM | marketbeat.comHow Do Investors Really Feel About Haemonetics?March 12 at 1:11 PM | benzinga.comHaemonetics Co. (NYSE:HAE) Shares Sold by Victory Capital Management Inc.Victory Capital Management Inc. lowered its position in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 2.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 271,082 shares of theMarch 12 at 3:34 AM | marketbeat.comTradeLink Capital LLC Invests $902,000 in Haemonetics Co. (NYSE:HAE)TradeLink Capital LLC purchased a new position in Haemonetics Co. (NYSE:HAE - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 11,557 shares of the medical instruments supplier's stock, valued at approximatMarch 10, 2025 | marketbeat.comAMG National Trust Bank Acquires New Position in Haemonetics Co. (NYSE:HAE)AMG National Trust Bank acquired a new stake in Haemonetics Co. (NYSE:HAE - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 9,744 shares of the medical instruments supplier's stock, valued atMarch 9, 2025 | marketbeat.comHaemonetics Co. (NYSE:HAE) Shares Bought by Global Alpha Capital Management Ltd.Global Alpha Capital Management Ltd. increased its position in Haemonetics Co. (NYSE:HAE - Free Report) by 70.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 17,101 shares of the medical instrumenMarch 9, 2025 | marketbeat.comBank of New York Mellon Corp Sells 15,785 Shares of Haemonetics Co. (NYSE:HAE)Bank of New York Mellon Corp lessened its holdings in Haemonetics Co. (NYSE:HAE - Free Report) by 3.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 386,489 shares of the medical instruments supplier's stock after selMarch 9, 2025 | marketbeat.comAnalysts Set Haemonetics Co. (NYSE:HAE) Price Target at $101.67March 9, 2025 | americanbankingnews.comHaemonetics Co. (NYSE:HAE) Receives Average Recommendation of "Moderate Buy" from BrokeragesShares of Haemonetics Co. (NYSE:HAE - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the nine analysts that are currently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, one has given a hold raMarch 6, 2025 | marketbeat.comHaemonetics Co. (NYSE:HAE) Sees Large Growth in Short InterestHaemonetics Co. (NYSE:HAE - Get Free Report) saw a significant increase in short interest in the month of February. As of February 15th, there was short interest totalling 6,830,000 shares, an increase of 30.3% from the January 31st total of 5,240,000 shares. Based on an average trading volume of 792,300 shares, the days-to-cover ratio is presently 8.6 days. Currently, 13.8% of the shares of the company are sold short.March 5, 2025 | marketbeat.comHaemonetics appoints new executive leadershiMarch 5, 2025 | investing.comJ.P. Morgan Remains a Buy on Haemonetics (HAE)March 4, 2025 | markets.businessinsider.comHaemonetics Names Chan Chief Operating OfficerMarch 4, 2025 | marketwatch.comHaemonetics announces updates to its Executive Leadership teamMarch 4, 2025 | markets.businessinsider.comHaemonetics Announces Executive Leadership UpdatesMarch 3, 2025 | prnewswire.comPharvaris Presents Long-Term Clinical Data of Deucrictibant for the Prevention and Treatment of HAE Attacks at the 2025 AAAAI/WAO Joint CongressMarch 3, 2025 | globenewswire.comHaemonetics Co. (NYSE:HAE) Shares Bought by Fisher Asset Management LLCFisher Asset Management LLC boosted its stake in Haemonetics Co. (NYSE:HAE - Free Report) by 3.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 711,774 shares of the medical instruments supplier's stock after bMarch 2, 2025 | marketbeat.comLos Angeles Capital Management LLC Sells 7,539 Shares of Haemonetics Co. (NYSE:HAE)Los Angeles Capital Management LLC reduced its position in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 31.5% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 16,415 shares of the medical instruments supplier's stock aMarch 2, 2025 | marketbeat.comHaemonetics (NYSE:HAE) Shares Up 3.5% - Should You Buy?Haemonetics (NYSE:HAE) Shares Up 3.5% - Here's WhyFebruary 24, 2025 | marketbeat.comHaemonetics to Present at Raymond James 46th Annual Institutional Investors ConferenceFebruary 24, 2025 | prnewswire.comQ3 EPS Estimates for Haemonetics Increased by Zacks ResearchHaemonetics Co. (NYSE:HAE - Free Report) - Equities research analysts at Zacks Research boosted their Q3 2026 earnings per share estimates for shares of Haemonetics in a research note issued on Monday, February 17th. Zacks Research analyst R. Department now anticipates that the medical instrumentFebruary 21, 2025 | marketbeat.comVan ECK Associates Corp Buys Shares of 39,620 Haemonetics Co. (NYSE:HAE)Van ECK Associates Corp bought a new stake in shares of Haemonetics Co. (NYSE:HAE - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 39,620 shares of the medical instruments supplier's stFebruary 21, 2025 | marketbeat.com4,086 Shares in Haemonetics Co. (NYSE:HAE) Acquired by Empowered Funds LLCEmpowered Funds LLC acquired a new position in shares of Haemonetics Co. (NYSE:HAE - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund acquired 4,086 shares of the medical instruments supplier's stock, valued at approximately $319,000. A numbFebruary 21, 2025 | marketbeat.comHaemonetics: Almost Blood In The StreetsFebruary 20, 2025 | seekingalpha.comHaemonetics FY2025 EPS Forecast Lowered by Zacks ResearchHaemonetics Co. (NYSE:HAE - Free Report) - Zacks Research lowered their FY2025 earnings per share estimates for Haemonetics in a research note issued on Monday, February 17th. Zacks Research analyst R. Department now expects that the medical instruments supplier will earn $4.56 per share for theFebruary 20, 2025 | marketbeat.comVontobel Holding Ltd. Acquires 8,133 Shares of Haemonetics Co. (NYSE:HAE)Vontobel Holding Ltd. boosted its holdings in Haemonetics Co. (NYSE:HAE - Free Report) by 166.7% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 13,011 shares of the medical instruments supplier's stock afterFebruary 19, 2025 | marketbeat.comHaemonetics Co. (NYSE:HAE) Short Interest Up 5.6% in JanuaryHaemonetics Co. (NYSE:HAE - Get Free Report) was the target of a significant growth in short interest in the month of January. As of January 31st, there was short interest totalling 5,240,000 shares, a growth of 5.6% from the January 15th total of 4,960,000 shares. Approximately 10.6% of the shares of the company are sold short. Based on an average trading volume of 781,800 shares, the short-interest ratio is currently 6.7 days.February 18, 2025 | marketbeat.comAstria Therapeutics: A High-Conviction Bet On HAEFebruary 17, 2025 | seekingalpha.comHaemonetics (NYSE:HAE) Downgraded by StockNews.com to HoldStockNews.com downgraded shares of Haemonetics from a "buy" rating to a "hold" rating in a research note on Saturday.February 15, 2025 | marketbeat.comHaemonetics Co. (NYSE:HAE) Position Increased by Allspring Global Investments Holdings LLCAllspring Global Investments Holdings LLC raised its position in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 0.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 801,049 shares of the medical insFebruary 14, 2025 | marketbeat.comHaemonetics' (NYSE:HAE) Earnings Offer More Than Meets The EyeFebruary 13, 2025 | finance.yahoo.comRetirement Systems of Alabama Sells 116,501 Shares of Haemonetics Co. (NYSE:HAE)Retirement Systems of Alabama cut its stake in Haemonetics Co. (NYSE:HAE - Free Report) by 65.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 61,068 shares of the medical instruments supplier's stock after sellingFebruary 11, 2025 | marketbeat.comJanney Montgomery Scott LLC Makes New Investment in Haemonetics Co. (NYSE:HAE)Janney Montgomery Scott LLC bought a new stake in Haemonetics Co. (NYSE:HAE - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 5,147 shares of the medical instruments supplier's stock, valued atFebruary 11, 2025 | marketbeat.comHaemonetics Co. (NYSE:HAE) Shares Sold by SG Americas Securities LLCSG Americas Securities LLC lowered its stake in Haemonetics Co. (NYSE:HAE - Free Report) by 82.4% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 1,732 shares of the medical instruments supplier's stock after selling 8,100 shares during the period. SG Americas SFebruary 11, 2025 | marketbeat.comHaemonetics (NYSE:HAE) Sets New 52-Week Low After Analyst DowngradeHaemonetics (NYSE:HAE) Hits New 12-Month Low After Analyst DowngradeFebruary 10, 2025 | marketbeat.comHaemonetics downgraded at Bank of America on revised FY25 outlookFebruary 9, 2025 | msn.comHaemonetics Co. (NYSE:HAE) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesHaemonetics Co. (NYSE:HAE - Get Free Report) has received a consensus rating of "Moderate Buy" from the nine ratings firms that are currently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, one has given a hold recommendation,February 9, 2025 | marketbeat.comHaemonetics price target lowered to $115 from $120 at Raymond JamesFebruary 8, 2025 | markets.businessinsider.comHaemonetics (NYSE:HAE) Upgraded to "Buy" at StockNews.comStockNews.com raised shares of Haemonetics from a "hold" rating to a "buy" rating in a report on Friday.February 7, 2025 | marketbeat.comHaemonetics price target lowered to $100 from $125 at JMP SecuritiesFebruary 7, 2025 | markets.businessinsider.comRaymond James Reaffirms Strong-Buy Rating for Haemonetics (NYSE:HAE)Raymond James reiterated a "strong-buy" rating and set a $115.00 price target (down from $120.00) on shares of Haemonetics in a research note on Friday.February 7, 2025 | marketbeat.comJMP Securities Has Lowered Expectations for Haemonetics (NYSE:HAE) Stock PriceJMP Securities lowered their target price on Haemonetics from $125.00 to $100.00 and set a "market outperform" rating on the stock in a research note on Friday.February 7, 2025 | marketbeat.comHaemonetics Corporation (HAE) Q3 2025 Earnings Call TranscriptFebruary 7, 2025 | seekingalpha.comHaemonetics price target lowered to $95 from $108 at BarringtonFebruary 7, 2025 | markets.businessinsider.comHaemonetics price target lowered to $90 from $115 at MizuhoFebruary 7, 2025 | markets.businessinsider.comHaemonetics Third Quarter 2025 Earnings: Misses ExpectationsFebruary 7, 2025 | finance.yahoo.comNeedham & Company LLC Lowers Haemonetics (NYSE:HAE) Price Target to $108.00Needham & Company LLC reduced their target price on Haemonetics from $112.00 to $108.00 and set a "buy" rating on the stock in a research note on Friday.February 7, 2025 | marketbeat.comHaemonetics (NYSE:HAE) Downgraded by Bank of America to UnderperformBank of America cut shares of Haemonetics from a "neutral" rating to an "underperform" rating and lowered their target price for the company from $95.00 to $68.00 in a research note on Friday.February 7, 2025 | marketbeat.com Remove Ads Get Haemonetics News Delivered to You Automatically Sign up to receive the latest news and ratings for HAE and its competitors with MarketBeat's FREE daily newsletter. Email Address HAE Media Mentions By Week HAE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HAE News Sentiment▼1.370.76▲Average Medical News Sentiment HAE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HAE Articles This Week▼106▲HAE Articles Average Week Remove Ads Get Haemonetics News Delivered to You Automatically Sign up to receive the latest news and ratings for HAE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Align Technology News Merit Medical Systems News DENTSPLY SIRONA News ICU Medical News QuidelOrtho News Neogen News STAAR Surgical News Cerus News OraSure Technologies News Anika Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:HAE) was last updated on 3/15/2025 by MarketBeat.com Staff From Our PartnersHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Haemonetics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Haemonetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
